Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis is an autosomal-recessive disease caused by mutations in the CLDN16 or CLDN19 genes, which encode tight junction-associated proteins, claudin-16 and-19. The resultant tubulopathy leads to urinary loss of Mg2 and Ca 2, with subsequent nephrocalcinosis and end-stage renal disease (ESRD). An 18-year-old boy presented with chronic kidney disease and proteinuria, as well as hypomagnesaemia, hypercalciuria and nephrocalcinosis. A kidney biopsy revealed tubular atrophy, interstitial fibrosis and segmental sclerosis of some glomeruli. Two novel mutations in the CLDN16 gene were identified: c.340C>T (nonsense) and c.4275G>A (splice site). The patient reached ESRD at 23 and benefited from kidney transplantation. © 2014 The Author 2014.
CITATION STYLE
Hanssen, O., Castermans, E., Bovy, C., Weekers, L., Erpicum, P., Dubois, B., … Jouret, F. (2014). Two novel mutations of the CLDN16 gene cause familial hypomagnesaemia with hypercalciuria and nephrocalcinosis. Clinical Kidney Journal, 7(3), 282–285. https://doi.org/10.1093/ckj/sfu019
Mendeley helps you to discover research relevant for your work.